Valuation : Isodiol International Inc.

Market Cap 3.91M 2.82M 2.42M 2.27M 2.08M 269M 3.92M 26.85M 10.5M 136M 10.59M 10.36M 449M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.59M 5.66M 5.29M 4.85M 629M 9.16M 62.7M 24.51M 317M 24.74M 24.2M 1.05B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.29
10 years 0
Extreme 1.0E-6
16.9
Manager TitleAgeSince
Chief Executive Officer - 23/05/2017
Director of Finance/CFO - -
Corporate Officer/Principal - 29/08/2018
Director TitleAgeSince
Director/Board Member - 23/05/2017
Director/Board Member - 29/08/2018
Director/Board Member - 20/11/2018
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 128
+1.01%+1.01%-13.78%-5.57% 13.27B
+1.98%+0.33%-35.14%-57.05% 4.97B
+1.85%-5.05%-6.75%-2.34% 4.65B
+1.58%-4.23%-1.29%-28.74% 4.04B
+1.01%+0.61%-21.17%+5.44% 3.59B
+2.21%+3.87%-6.13%-3.71% 3.46B
-0.47%-4.16%-13.69%+11.83% 3.29B
+0.86%-3.04%-19.63%-15.55% 2.43B
+1.82%-1.23%-31.46%-11.34% 1.71B
Average +1.19%-0.99%-16.56%-11.89% 4.14B
Weighted average by Cap. +1.28%-0.82%-15.40%-11.97%

Financials

2018 2019
Net sales 19.14M 13.8M 11.85M 11.09M 10.16M 1.32B 19.19M 131M 51.36M 664M 51.83M 50.71M 2.2B 22.25M 16.05M 13.78M 12.9M 11.81M 1.53B 22.31M 153M 59.7M 773M 60.26M 58.95M 2.56B
Net income -36.02M -25.98M -22.3M -20.88M -19.12M -2.48B -36.12M -247M -96.66M -1.25B -97.56M -95.45M -4.14B -126M -90.83M -77.97M -72.99M -66.84M -8.67B -126M -864M -338M -4.37B -341M -334M -14.47B
Net Debt -15.55M -11.22M -9.63M -9.01M -8.25M -1.07B -15.59M -107M -41.73M -540M -42.11M -41.2M -1.79B 5.22M 3.77M 3.23M 3.03M 2.77M 360M 5.24M 35.85M 14.01M 181M 14.14M 13.84M 600M
Logo Isodiol International Inc.
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-
Date Price Change Volume
27/08/26 US$0.000001 0.00% 550
  1. Stock Market
  2. Stocks
  3. ISOLF Stock